93 reports of this reaction
2.5% of all VECURONIUM BROMIDE reports
#9 most reported adverse reaction
BRADYCARDIA is the #9 most commonly reported adverse reaction for VECURONIUM BROMIDE, manufactured by Eugia US LLC. There are 93 FDA adverse event reports linking VECURONIUM BROMIDE to BRADYCARDIA. This represents approximately 2.5% of all 3,750 adverse event reports for this drug.
Patients taking VECURONIUM BROMIDE who experience bradycardia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BRADYCARDIA is a less commonly reported adverse event for VECURONIUM BROMIDE, but still significant enough to appear in the safety profile.
In addition to bradycardia, the following adverse reactions have been reported for VECURONIUM BROMIDE:
The following drugs have also been linked to bradycardia in FDA adverse event reports:
BRADYCARDIA has been reported as an adverse event in 93 FDA reports for VECURONIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BRADYCARDIA accounts for approximately 2.5% of all adverse event reports for VECURONIUM BROMIDE, making it a notable side effect.
If you experience bradycardia while taking VECURONIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.